Top

Published in:

01-02-2019 | Research Article

iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer

Published in: Clinical and Translational Oncology | Issue 2/2019

Abstract

Purpose

The aim of this study is to explore the roles of β-catenin, decorin, septin-7, and S100A10 expression in colorectal cancer development.

Methods

Twenty-five BALB/c mice were divided into five groups; four groups were administrated N,N-dimethylhydrazine for 0, 10, 15, and 20 weeks, and one group was administrated normal saline for 20 weeks. The colons were collected for histopathological analysis. Protein samples prepared from the frozen colon tissues of mice treated with N,N-dimethylhydrazine for the different time points were evaluated using the isobaric tags for relative and absolute quantification (iTRAQ) labeling technique coupled with the 2D liquid chromatography–tandem mass spectrometry analysis. Based on the proteomic analysis results, immunohistochemical staining of β-catenin, decorin, septin-7, and S100A10 was performed in paraffin-embedded mice colorectal tissue, and 53 cases of human hereditary polyposis colorectal cancer samples.

Results

Colorectal cancer was observed in mice treated with N,N-dimethylhydrazine for 20 weeks, and adenomas were observed in mice subjected to the 10-, and 15-week treatments. Seventy-two differentially expressed proteins were involved in the development of cancer as per the iTRAQ and spectrometry analysis. In normal epithelium, adenoma, and cancer from human hereditary polyposis colorectal cancer, S100A10 expression (c2 = 100.989, P = 0.000) was highest in cancer, whereas decorin (c2 = 12.852, P = 0.002) and septin-7 (c2 = 66.519, P = 0.002) expressions were highest in the normal epithelium, which was confirmed via immunohistochemical staining.

Conclusions

The subcellular localization of β-catenin and decorin, septin-7, and S100A10 expressions are associated with the development of colorectal cancer in mice after N,N-dimethylhydrazine treatment and in human hereditary polyposis colorectal cancers.

Available only for authorised users

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009;302(16):1790–5. https://doi.org/10.1001/jama.2009.1529.CrossRefPubMedPubMedCentral

Miladi-Abdennadher I, Amouri A, Ayadi L, Khabir A, Ellouze S, Tahri N, et al. A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Tunisian family with FAP. Fam Cancer. 2011;10(3):567–71. https://doi.org/10.1007/s10689-011-9451-0.CrossRefPubMed

Song G, Yuan Y, Zheng F, Yang N, et al. Novel insertion mutation p.Asp610GlyfsX23 in APC gene causes familial adenomatous polyposis in Chinese families. Gene. 2013;516(2):204–8. https://doi.org/10.1016/j.gene.2012.12.077.CrossRefPubMed

Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet. 1998;62(6):1290–301. https://doi.org/10.1086/301883.CrossRefPubMedPubMedCentral

Zhang D, Fei F, Li S, Zhao Y, Yang Z, Qu J, et al. The role of beta-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer. J Cancer. 2017;8(11):2114–23. https://doi.org/10.7150/jca.19723.CrossRefPubMedPubMedCentral

Zhang Z, Liang S, Huang H, Wang D, Zhang X, Wu J, et al. A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis. Oncotarget. 2016;7(31):50392–400. https://doi.org/10.18632/oncotarget.10408.CrossRefPubMedPubMedCentral

Svitina H, Kyryk V, Skrypkina I, Kuchma M, Bukreieva T, Areshkov P, et al. Placenta-derived multipotent cells have no effect on the size and number of DMH-induced colon tumors in rats. Exp Ther Med. 2017;14(3):2135–47. https://doi.org/10.3892/etm.2017.4792.CrossRefPubMedPubMedCentral

Bekusova VV, Patsanovskii VM, Nozdrachev AD, Trashkov AP, Artemenko MR, Anisimov VN. Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats. Cancer Biol Med. 2017;14(1):100–7. https://doi.org/10.20892/j.issn.2095-3941.2016.0088.CrossRefPubMedPubMedCentral

Kuznietsova HM, Luzhenetska VK, Kotlyar IP, Rybalchenko VK. Effects of 5-Amyno-4-(1,3-benzothyazol-2-yn)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrol-3-one intake on digestive system in a rat model of colon cancer. Sci World J. 2015;2015:376576. https://doi.org/10.1155/2015/376576.CrossRef

10.

Zhang S, Li M, Zhang D, Xu S, Wang X, Liu Z, et al. Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab Investig J Tech Methods Pathol. 2009;89(5):575–86. https://doi.org/10.1038/labinvest.2009.20.CrossRef

11.

Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene. 2014;33(1):116–28. https://doi.org/10.1038/onc.2013.96.CrossRefPubMed

12.

Sun B, Zhang D, Zhang S, Zhang W, Guo H, Zhao X. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett. 2007;249(2):188–97. https://doi.org/10.1016/j.canlet.2006.08.016.CrossRefPubMed

13.

Zhang S, Mercado-Uribe I, Liu J. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel. Int J Cancer. 2014;134(3):508–18. https://doi.org/10.1002/ijc.28319.CrossRefPubMed

14.

Jia L, Zhang S, Ye Y, Li X, Mercado-Uribe I, Bast RC Jr, et al. Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells. Cancer Lett. 2012;326(2):176–82. https://doi.org/10.1016/j.canlet.2012.08.004.CrossRefPubMedPubMedCentral

15.

Sun B, Zhang S, Zhang D, Li Y, Zhao X, Luo Y, et al. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res. 2008;14(21):7050–9. https://doi.org/10.1158/1078-0432.CCR-08-0520.CrossRefPubMed

16.

Migliore L, Migheli F, Spisni R, Coppede F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol. 2011;2011:792362. https://doi.org/10.1155/2011/792362.CrossRefPubMedPubMedCentral

17.

Katono K, Sato Y, Jiang SX, Kobayashi M, Saito K, Nagashio R, et al. Clinicopathological significance of S100A10 expression in lung adenocarcinomas. Asian Pacific J Cancer Prev APJCP. 2016;17(1):289–94.CrossRef

18.

Hou Y, Yang L, Mou M, Hou Y, Zhang A, Pan N, et al. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Investig. 2008;26(8):809–15. https://doi.org/10.1080/07357900801898664.CrossRef

19.

Phipps KD, Surette AP, O’Connell PA, Waisman DM. Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Can Res. 2011;71(21):6676–83. https://doi.org/10.1158/0008-5472.CAN-11-1748.CrossRef

20.

Tan Y, Ma SY, Wang FQ, Meng HP, Mei C, Liu A, et al. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncol Rep. 2011;26(4):853–9. https://doi.org/10.3892/or.2011.1353.CrossRefPubMed

21.

Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, et al. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res. 2007;27(4C):2679–83.PubMed

22.

Mostowy S, Cossart P. Septins: the fourth component of the cytoskeleton. Nat Rev Mol Cell Biol. 2012;13(3):183–94. https://doi.org/10.1038/nrm3284.CrossRefPubMed

23.

Kinoshita A, Noda M, Kinoshita M. Differential localization of septins in the mouse brain. J Comp Neurol. 2000;428(2):223–39.CrossRefPubMed

24.

Ihara M, Kinoshita A, Yamada S, Tanaka H, Tanigaki A, Kitano A, et al. Cortical organization by the septin cytoskeleton is essential for structural and mechanical integrity of mammalian spermatozoa. Dev Cell. 2005;8(3):343–52. https://doi.org/10.1016/j.devcel.2004.12.005.CrossRefPubMed

25.

Jia ZF, Huang Q, Kang CS, Yang WD, Wang GX, Yu SZ, et al. Overexpression of septin 7 suppresses glioma cell growth. J Neurooncol. 2010;98(3):329–40. https://doi.org/10.1007/s11060-009-0092-1.CrossRefPubMed

26.

Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, et al. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol. 2011;22(2):86–96. https://doi.org/10.1007/s12022-011-9157-8.CrossRefPubMed

27.

Igci YZ, Erkilic S, Arslan A. Septin 7 immunoexpression in papillary thyroid carcinoma: a preliminary study. Pathol Res Pract. 2014;210(7):426–31. https://doi.org/10.1016/j.prp.2014.02.009.CrossRefPubMed

28.

Yoon AR, Hong J, Yun CO. Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis. Oncotarget. 2017;8(44):76666–85. https://doi.org/10.18632/oncotarget.20800.CrossRefPubMedPubMedCentral

29.

Bostrom P, Sainio A, Eigeliene N, Jokilammi A, Elenius K, Koskivuo I, et al. Human metaplastic breast carcinoma and decorin. Cancer Microenviron. 2017. https://doi.org/10.1007/s12307-017-0195-8.CrossRefPubMedPubMedCentral

30.

Neill T, Schaefer L, Iozzo RV. Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev. 2016;97:174–85. https://doi.org/10.1016/j.addr.2015.10.016.CrossRefPubMed

Title: iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer
Publication date: 01-02-2019
Published in: Clinical and Translational Oncology / Issue 2/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-018-1912-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

Molecular biomarkers for prognosis of gastrointestinal stromal tumor

The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients

Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer